Background: Short sprints have been shown to prevent exercise induced hypoglycaemia in controlled laboratory settings. Using a randomised controlled study design, we tested the hypothesis that incorporating sprinting into moderate intensity exercise can reduce the incidence of exercise mediated hypoglycaemia in individuals with T1D in a real-life setting.

Methods: Individuals with T1D, diagnosed for >1 year, aged 14-35 years, with an HbA1c of ≤9% were recruited into a prospective randomised controlled cross over study. Participants completed three 14-day periods in random order. In one period participants adhered to their usual exercise management (control period), in the other 2 periods, participants additionally incorporated 10s (every 20 mins) or 4s sprints (every 2 mins) into moderate intensity exercise. Outcome measures included the incidence of hypoglycaemia (defined as sensor glucose readings <3.1mmol/L for ≥ to 20 minutes) over the 14-day period; and percent time spent <3.1mmol/L and <3.5mmol/L. CGM data were analysed using a mixed model approach.

Results: 24 participants completed the study, performing a total of 420 exercise episodes. The 10s period was associated with fewer hypoglycaemia events (<3.1mmol/L) than the control period (adjusted incidence rate ratio of 0.67, 95% CI 0.46-0.98: p=0.04), with a hypoglycaemia incidence rate of 0.40 (95% CI 0.26-0.55), 0.33 (95% CI 0.21-0.45) and 0.28 (95% CI 0.17-0.38) events per day in the control, 4s and 10s periods respectively. The 10s period was associated with a reduction in time spent <3.5mmol/L (control vs. 10s period, 3.1% vs. 2.1%, p=0.03) and time spent <3.1mmol/L (control vs.10s period, 1.9% vs. 1.2%, p= 0.03) compared to the control period. There was no increase in nocturnal hypoglycaemia during the sprinting periods.

Conclusion: In a real-life setting the inclusion of 10s sprints into moderate intensity exercise reduces the incidence of hypoglycaemia, without increasing the risk of nocturnal hypoglycaemia.

Disclosure

T. Chetty: None. H. Roby: None. N. Paramalingam: None. J. Dart: None. W. Soon: None. G.J. Smith: None. V.B. Shetty: None. P.A. Fournier: None. T. Jones: None. E.A. Davis: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.